| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/08/2006 | US20060122125 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 06/08/2006 | US20060122124 Therapeutic agent |
| 06/08/2006 | US20060122123 Hepatitis C; 1-benzyloxycarbonylamino-2-vinyl-cyclopropyl)-phenyl-phosphinic acid ethyl ester |
| 06/08/2006 | US20060122122 Antimicrobial peptides and use thereof |
| 06/08/2006 | US20060122121 Modified alpha-MSH peptides and derivatives thereof |
| 06/08/2006 | US20060122120 Method of reducing the effects of Abeta and compositions therefore |
| 06/08/2006 | US20060122119 Peptides for use in antitumor immunotherapy |
| 06/08/2006 | US20060122118 Therapeutic compositions and methods of using same |
| 06/08/2006 | US20060122117 Method of treating retinopathies and disorders associated with blood vessel loss |
| 06/08/2006 | US20060122116 Treatment for disorders of the peripheral nervous system |
| 06/08/2006 | US20060122115 Use of SERP-1 as an antiplatelet agent |
| 06/08/2006 | US20060122114 Antibodies to heregulin 2 |
| 06/08/2006 | US20060122113 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
| 06/08/2006 | US20060122112 Method for preventing or treating osteosarcoma |
| 06/08/2006 | US20060122111 Regeneration and neogenesis of retinal visual cell otx2 gene |
| 06/08/2006 | US20060122110 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system |
| 06/08/2006 | US20060122109 Composition for preventing the formation of new scar comprising bmp-7 |
| 06/08/2006 | US20060122108 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/08/2006 | US20060122106 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 06/08/2006 | US20060122105 Method of improing the growth performance of an animal |
| 06/08/2006 | US20060122104 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells |
| 06/08/2006 | US20060122103 Dalfopristine/quinupristine combinations with cefpirome |
| 06/08/2006 | US20060122102 Methods and preparations for curing critically ill patients |
| 06/08/2006 | US20060122101 Drug for preventing, regulating or treating adhesion |
| 06/08/2006 | US20060122100 Melanin extinguisher |
| 06/08/2006 | US20060122099 Method for infusing insulin to a subject to improve impaired total body tissue glucose processing |
| 06/08/2006 | US20060122098 System for infusing insulin to a subject to imporve impaired total body tissue glucose processing |
| 06/08/2006 | US20060122097 Uptake of macromolecules |
| 06/08/2006 | US20060122096 Reversible modification of amine-containing compounds |
| 06/08/2006 | US20060122095 Mucus formulation for mucosal surfaces and uses thereof |
| 06/08/2006 | US20060121566 Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor |
| 06/08/2006 | US20060121554 Regulation of human RTA-like GPCR |
| 06/08/2006 | US20060121538 Peptides having affinity for the gp120 viral protein and use thereof |
| 06/08/2006 | US20060121527 Oncoprotein protein kinase |
| 06/08/2006 | US20060121518 Polypeptide encoded by nucleic acid of given sequence; Glycerol-3-phosphate; modulators of cellular metabolism, energy homeostasis, signal transduction and cell proliferation |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121498 Enzymes involved in apoptosis |
| 06/08/2006 | US20060121485 Compounds and methods for detection of carcinomas and their precursor lesions |
| 06/08/2006 | US20060121480 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121462 Receptor and screening methods |
| 06/08/2006 | US20060121460 Toll-like receptor 11 |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121456 Isolated human ras-like proteins acid molecules encoding these human ras-like proteins, and uses thereof |
| 06/08/2006 | US20060121454 diagnosis and treatment of carcinomas, especially breast cancers |
| 06/08/2006 | US20060121121 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion |
| 06/08/2006 | US20060121120 Sustained release ionic conjugate |
| 06/08/2006 | US20060121119 Process for producing nanoparticles of paclitaxel and albumin |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/08/2006 | US20060121115 Composition having gelling properties for the prolonged delivery of bioactive substances |
| 06/08/2006 | US20060121083 Anti-microbial medical implants and uses thereof |
| 06/08/2006 | US20060121069 Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
| 06/08/2006 | US20060121057 Combination of local botulinum toxin and oral triptan drug administration; preventing overuse; reducing pain sensory output |
| 06/08/2006 | US20060121056 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 06/08/2006 | US20060121046 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 06/08/2006 | US20060121041 Gpcs as modifiers of the irrtk p21 pathways and methods of use |
| 06/08/2006 | US20060121039 Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration |
| 06/08/2006 | US20060121037 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/08/2006 | US20060121035 Methods for treating diabetes |
| 06/08/2006 | US20060121034 Treatment for alzheimer's disease and related conditions |
| 06/08/2006 | US20060121033 Using antibodies which bind specifically to DC-SIGN; Agents that bind to ICAM-3 are used to block inhibition of activation of macrophages by DC-SIGN-ICAM-3 interaction and cause inhibition of rheumatoid arthritis symptoms |
| 06/08/2006 | US20060121030 Use of cd 137 antagonists for the treatment of tumors |
| 06/08/2006 | US20060121029 Method and composition for regulating the activity of regulatory t cells |
| 06/08/2006 | US20060121025 VEGF-related protein |
| 06/08/2006 | US20060121019 Compositions for treating cystic fibrosis |
| 06/08/2006 | US20060121018 Methods and compositions for targeting proteins across the blood brain barrier |
| 06/08/2006 | US20060121017 Compositions and methods for treating pancreatic insufficiency |
| 06/08/2006 | US20060121016 Methods and compositions for treatment of free radical injury |
| 06/08/2006 | US20060121010 Chorionic gonadotropin DNA vaccines and methods |
| 06/08/2006 | US20060121007 Generation of neuronal cells for use in the treatment of nervous system disorders; preparing nutrient broth contain nerve growth factor, inoculating with cells, producing neuronal precursor cells or glial precursor cells |
| 06/08/2006 | US20060121004 Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin |
| 06/08/2006 | US20060121003 In situ maturation of dendritic cells |
| 06/08/2006 | US20060121002 Methods and compositions for tissue regeneration |
| 06/08/2006 | US20060120999 Protein and peptide expression for passive immunity |
| 06/08/2006 | US20060120998 Deamidated interferon-beta |
| 06/08/2006 | US20060120997 Cancer therapeutic compositions |
| 06/08/2006 | US20060120996 Vaccine immunotherapy for immune suppressed patients |
| 06/08/2006 | US20060120995 Neoadjuvant genetic compositions and methods |
| 06/08/2006 | US20060120993 Treatment of lesions of the soft tissues |
| 06/08/2006 | US20060120992 Rapid dehydration of proteins |
| 06/08/2006 | US20060120973 powders containing human growth hormone; for treatment or prevention of growth retardation, growth hormone deficiency, or for control of HIV-related wasting and cachexia |
| 06/08/2006 | US20060120969 Inhalers used in the treatment of diabetes by delivering insulin by way of systemic dose delivery |
| 06/08/2006 | CA2601629A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | CA2595115A1 Fusion proteins for treating, preventing or ameliorating pain |
| 06/08/2006 | CA2593707A1 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 06/08/2006 | CA2593429A1 The lupac bifunctional marker and its use in protein production |
| 06/08/2006 | CA2591301A1 Laminin receptor binding molecule |
| 06/08/2006 | CA2590419A1 Modulation of ovulation |
| 06/08/2006 | CA2590384A1 Compositions and methods for the treatment of autism |
| 06/08/2006 | CA2589898A1 Modulation of ovulation |
| 06/08/2006 | CA2589833A1 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/08/2006 | CA2589523A1 Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions |
| 06/08/2006 | CA2589343A1 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof |
| 06/08/2006 | CA2589187A1 Protein allergen derivatives |
| 06/08/2006 | CA2589118A1 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
| 06/08/2006 | CA2588868A1 Remedy for alzheimer's disease |
| 06/08/2006 | CA2588801A1 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery |
| 06/08/2006 | CA2588292A1 Non-cytotoxic protein conjugates |
| 06/08/2006 | CA2587601A1 Diagnosis and treatment of alzheimer's disease |